| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 01/08/2009 | US20090012082 Mediators of Hedgehog Signaling Pathways, Compositions and Uses Related Thereto |
| 01/08/2009 | US20090012076 Tyrosine kinase inhibitors |
| 01/08/2009 | US20090012075 Fluorinated Arylamide Derivatives |
| 01/08/2009 | US20090012073 N-aroyl cyclic amines |
| 01/08/2009 | US20090012065 Therapeutic applications of pro-apoptotic benzodiazepines |
| 01/08/2009 | US20090012061 A Method of Treating Cancer |
| 01/08/2009 | US20090012060 Antitumor Agent |
| 01/08/2009 | US20090012059 Dipeptidyl peptidase inhibitors |
| 01/08/2009 | US20090012052 Method for treating er+ breast cancer |
| 01/08/2009 | US20090012045 Methods of Treating Cell Proliferative Disorders |
| 01/08/2009 | US20090012043 Inhibitors of polysialic acid de-n-acetylase and methods for using the same |
| 01/08/2009 | US20090012027 Biodegradable polyphosphoramidates for controlled release of bioactive substances |
| 01/08/2009 | US20090012024 Stem Cell Markers |
| 01/08/2009 | US20090012021 Delivery of Sirna by Neutral Lipid Compositions |
| 01/08/2009 | US20090012018 Inhibition of pancretic cancer cell growth |
| 01/08/2009 | US20090012010 Amino acid derivatives as calcium channel blockers |
| 01/08/2009 | US20090012008 Pharmaceutical Composition for Photodynamic Therapy and a Method for Treating Oncological Diseases by Using Said Composition |
| 01/08/2009 | US20090012006 Par-2 Antagonists |
| 01/08/2009 | US20090011991 Novel Curcuminoid-Factor VIIA Constructs as Suppressors of Tumor Growth and Angiogenesis |
| 01/08/2009 | US20090011986 Thiosuccinic Acid Derivatives and the Use Thereof |
| 01/08/2009 | US20090011981 Novel Inhibitors of Angiogenesis |
| 01/08/2009 | US20090011975 Targeted bone marrow protection agents |
| 01/08/2009 | US20090011499 for modulating or altering T cell function; found on lymphoid derived dendritic cells and display a limited homology to adhesion molecules; generating natural killer cells |
| 01/08/2009 | US20090011434 Methods And Compositions For Diagnosing Breast Cancer |
| 01/08/2009 | US20090011055 Plasminogen Activator Inhibitor-1 Inhibitors And Methods Of Use Thereof To Modulate Lipid Metabolism |
| 01/08/2009 | US20090011049 Methylation Markers for Prognosis and Treatment of Cancers |
| 01/08/2009 | US20090011047 Pharmaceutical compositions comprising of arsenous acid, its sodium salt and its derivatives intended for the treatment or urogenital cancer and its metastasis |
| 01/08/2009 | US20090011036 Drug containing hollow protein nanoparticles of particle-forming protein, fused with disease-treating target-cell-substance |
| 01/08/2009 | US20090011032 Methods for improved cryo-chemotherapy tissue ablation |
| 01/08/2009 | US20090010999 Complex Particles and Coated Complex Particles |
| 01/08/2009 | US20090010986 Polymeric gel delivery system for pharmaceuticals |
| 01/08/2009 | US20090010978 Green tea jewelry |
| 01/08/2009 | US20090010966 Modified diphtheria toxins |
| 01/08/2009 | US20090010953 Peptides of a melanoma antigen and their use in diagnostic, prophylactic, and therapeutic methods |
| 01/08/2009 | US20090010948 Anti-tumor vaccines delivered by dendritic cells devoid of interleukin-10 |
| 01/08/2009 | US20090010944 Oligosialic acid derivatives, methods of manufacture, and immunological uses |
| 01/08/2009 | US20090010936 Novel Stra6 Polypeptides |
| 01/08/2009 | US20090010935 Compositions and Methods of Treating Tumors |
| 01/08/2009 | US20090010933 inhibiting vascularization or angiogenesis using chimeric proteins, immunoglobulin-like domains of tyrosine kinase receptors |
| 01/08/2009 | US20090010927 Mapkap kinase-2 as a specific target for blocking proliferation of P53-defective cells |
| 01/08/2009 | US20090010925 Antibody variants |
| 01/08/2009 | US20090010923 Treatment of cancer with anti-muscarinic receptor agents |
| 01/08/2009 | US20090010919 Diagnostics and Therapeutics for Diseases Associated With Fibroblast Activation Protein (Fap) |
| 01/08/2009 | US20090010917 Targeted killing of a cell utilizing a chimeric polypeptide comprising a cell-specific targeting moiety and a signal transduction pathway factor; apoptosis-inducing factor |
| 01/08/2009 | US20090010913 Natural liniment for treatment of skin cancers |
| 01/08/2009 | US20090010912 Use of Alkaline Phosphatase for the Detoxification of Lps Present at Mucosal Barriers |
| 01/08/2009 | US20090010887 Method and composition for enhancing anti-angiogenic therapy |
| 01/08/2009 | US20090010886 Method for the Treatment of Myeloproliferative Diseases Using(+)-2-[1-(3-Ethoxy-4-Methoxyphenyl)-2- Methylsulfonylethyl]-4- Acetylaminoisoindoline-1,3- Dione |
| 01/08/2009 | US20090010883 Using endothelial growth factor specific immunoglobulin as therapeutic tool in treatment of metastatic gastric or stomach cancer |
| 01/08/2009 | US20090010881 Using endothelial growth factor specific immunoglobulin as therapeutic tool in treatment of bladder cancer |
| 01/08/2009 | US20090010878 Pulsatile dosing of gossypol for treatment of disease |
| 01/08/2009 | US20090010877 Methods for treatment prostate cancer using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione |
| 01/08/2009 | US20090010875 IL-7 Fusion Proteins |
| 01/08/2009 | US20090010846 Nitro-Imidazole Hypoxia Imaging Agents |
| 01/08/2009 | US20090010842 Methods for the early diagnosis of ovarian cancer |
| 01/08/2009 | US20090010841 Antiproliferative agents; as chimeric molecules to direct an effector (e.g. a cytotoxin, an imaging reagent, a drug, etc.) to a prostate tumor site; single chain antibody |
| 01/08/2009 | US20090010839 Avidin dimers effective in increasing the concentration of radioactive biotin in pretargeted radioimmunotherapy |
| 01/08/2009 | DE102007032158A1 Antitumormittel Antitumor agents |
| 01/08/2009 | CA2694284A1 Heterocyclic compounds useful as raf kinase inhibitors |
| 01/08/2009 | CA2693182A1 Compounds useful as raf kinase inhibitors |
| 01/08/2009 | CA2692506A1 Pyrimidyl cyclopentanes as akt protein kinase inhibitors |
| 01/08/2009 | CA2692502A1 Pyrimidyl cyclopentanes as akt protein kinase inhibitors |
| 01/08/2009 | CA2692495A1 Proteinases destroy cancer tumor's solid structure and kill cancer cells locally |
| 01/08/2009 | CA2692383A1 New chemical compounds |
| 01/08/2009 | CA2691734A1 Anti-muc17 antibody |
| 01/08/2009 | CA2691625A1 Substituted 6-anilinopurine derivatives as inhibitors of cytokinin oxidase/dehydrogenase and preparations containing these derivatives |
| 01/08/2009 | CA2691587A1 Potentiation of cancer chemotherapy by 7-(2,5-dihydro-4-imidazo [1,2-a] pyrine-3-yl-2,5-dioxo-ih-pyrrol-3-yl)-9-fluoro-1,2,3,4, tetrahydro-2-(1-piperidinyl-carbonyd-pyrrolo[3,2,1-jk][1,4]benzodiazepin |
| 01/08/2009 | CA2691459A1 Phthalazinone derivatives as inhibitors of parp-1 |
| 01/08/2009 | CA2691378A1 Compositions and methods for treating and diagnosing cancer |
| 01/08/2009 | CA2691178A1 Novel triazene compounds for the treatment of cancer |
| 01/08/2009 | CA2691107A1 Pharmaceutical combination of nsaid and prostaglandin compound |
| 01/08/2009 | CA2689116A1 1-benzylpyrazole derivatives, preparation thereof and therapeutic use thereof |
| 01/07/2009 | EP2011877A2 Conjugates for the modulation of immune responses |
| 01/07/2009 | EP2011870A1 Mutant polypeptide having effector function |
| 01/07/2009 | EP2011869A1 Novel anti-cd98 antibody |
| 01/07/2009 | EP2011802A2 Anti-CD40 monoclonal antibody |
| 01/07/2009 | EP2011801A1 Immunoconjugates having high binding affinity |
| 01/07/2009 | EP2011800A2 Inhibitors of caspase |
| 01/07/2009 | EP2011520A1 Kit for Radiolabeling Proteins with Yttrium-90 |
| 01/07/2009 | EP2011517A1 Polynucleotide binding complexes comprising sterols and saponin |
| 01/07/2009 | EP2011513A1 Therapeutic agents for alzheimer's disease and cancer |
| 01/07/2009 | EP2010658A2 Gene therapy for cancer using small interfering rna specific to ant2 and a method to overcome tolerance to antitumor agent |
| 01/07/2009 | EP2010570A2 Therapy against cathepsin s |
| 01/07/2009 | EP2010567A2 Antibody compositions and methods for treatment of neoplastic disease |
| 01/07/2009 | EP2010533A2 Process for the preparation of 2,6,9-trisubstituted purines |
| 01/07/2009 | EP2010528A2 6-o-substituted benzoxazole and benzothiazole compounds and methods of inhibiting csf-1r signaling |
| 01/07/2009 | EP2010526A1 Benzimidazole 5-sulfonamide derivatives as cannabinoid 1 (cb1) receptor ligands |
| 01/07/2009 | EP2010524A2 S1p receptor modulating compounds |
| 01/07/2009 | EP2010521A1 Indazole compounds and methods for inhibition of cdc7 |
| 01/07/2009 | EP2010511A1 Chromen-2-one derivatives |
| 01/07/2009 | EP2010504A1 Quinazolin-4-one derivatives, process for their preparation and pharmaceutical compositions containing them |
| 01/07/2009 | EP2010486A2 Diazeniumdiolated non-steroidal anti-inflammatory drugs, compositions thereof, and related methods |
| 01/07/2009 | EP2010483A2 1.alpha.-hydroxy-2-(3'-hydroxypropylidene)-19-nor-vitamin d compounds and methods of making and use thereof |
| 01/07/2009 | EP2010221A2 Antibody-rnase-conjugate |
| 01/07/2009 | EP2010212A2 Anti ku70 internalizing antibodies |
| 01/07/2009 | EP2010206A1 Cystine-knot fold cytokine |
| 01/07/2009 | EP2010204A2 Inhibition of tumour growth |
| 01/07/2009 | EP2010191A2 Anticancer treatment with a combination of taxanes and 13-deoxyanthracyclines |
| 01/07/2009 | EP2010182A2 Use of c-src inhibitors in combination with a pyrimidylaminobenzamide compound for the treatment of leukemia |
| 01/07/2009 | EP2010181A1 Methods of treating cell proliferative disorders by using pyrimidinediamine compounds |